Genes2Me is India's leading IVD solutions manufacturer which offers NGS clinical panels, molecular POC testing solutions, RT-PCR kits, rapid antigen/antibody testing kits, and molecular biology reagents. Additionally, Company is also a renowned genetic testing service provider with a wide range of tests targeting infectious and non-infectious diseases, oncology, rare diseases, and prenatal/postnatal genetic diseases. NGS clinical assays from Genes2Me allow targeted testing for Oncology, Liquid Biopsy, cardiovascular conditions, neurological disorders, HLA typing, etc. With engaging innovative approaches and new ideas, the company’s flagship products Rapi-Q/ Rapi-Q HT and Rapid POC RT-PCR device are revolutionary innovations that shall change the paradigm of molecular Point of Care testing across the world. Brands: CliSeq NGS clinical panels, PanCan, Med4Me, Exome CliSeq, CliSeq LiqBio, Rapi-Q / Rapi-Q HT, Rapi-X 16, Rapi-X 96, RapiCycler 96, RT-Direct, CoviEasy, LeoNext
| Website | https://www.genes2me.com |
| Revenue | $6.9 million |
| Employees | 112 (74 on RocketReach) |
| Founded | 2016 |
| Phone | +91 99100 55744 |
| Industry | Hospitals and Health Care, Biotechnology, Diagnostics, Science and Engineering, Diagnostic testing , Genetics, Genetic testing, Health Care, Genetic screening, Health Diagnostics, Microarray, Personal Health, Prenatal Testing , Wellness, Post natal testing, Genetic Counseling , Karyotyping , NIPT, DNA Testing, Genomekundli |
| Keywords | Next Generation Sequencing, Molecular Diagnostics, Ivd Solutions, Clinical Genomics, In Vitro Diagnostics, Genomics, Ngs Testing, Molecular Testing, Precision Medicine, Rapid Diagnostic Tests, Genetic Testing, Personalized Medicine, Molecular Biology Reagents, Ivd Market, Antigen Tests, Antibody Tests |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, BGI Genomics, Zymo Research Corp +40 more (view full list) |
Looking for a particular Genes2Me | Next Generation IVD solutions for Genomics employee's phone or email?
Genes2Me | Next Generation IVD solutions for Genomics Questions
The Genes2Me | Next Generation IVD solutions for Genomics annual revenue was $6.9 million in 2026.
Neeraj Gupta is the Founder and CEO of Genes2Me | Next Generation IVD solutions for Genomics.
74 people are employed at Genes2Me | Next Generation IVD solutions for Genomics.
Top Genes2Me | Next Generation IVD solutions for Genomics Employees
Related Companies
